119-HR3520
STAND Against Emerging Opioids Act
Last action was on 5-20-2025
SenateCurrent status is Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View Official Bill Information at congress.govNo users have voted for/against support on this bill yet. Be the first!
119th CONGRESS
1st Session
H. R. 3520
1. Short title2. Scheduling of tianeptine1. Short title
This Act may be cited as the "Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act" or the "STAND Against Emerging Opioids Act".
2. Scheduling of tianeptine
(a) In general - Section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end of schedule III the following:
(f) - Tianeptine, including its analogues, salts, isomers, and salts of isomers.
(b) Effective date - The amendment made by subsection (a) shall become effective on the date that is 90 days after the date of enactment of this Act.